Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC

NCT01063478 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: RAD001 (in addition to standard radiation and chemotherapy)

Sponsor

University of Chicago

Collaborators

[object Object]